Skip to main navigation Skip to search Skip to main content

Interrogating causality in the association of molecular and lifestyle factors with prostate and ovarian cancer risk

Student thesis: Doctoral Thesis › Doctor of Philosophy (PhD)

Abstract

Prostate and ovarian cancers are sex-specific cancers with few established risk factors.
Though several specific lifestyle and molecular factors have been proposed as risk factors for
these cancers in observational epidemiological studies, their causal relevance in disease onset
is unclear. In this thesis, I applied Mendelian randomization (MR) to more robustly appraise
causal relationships between previously reported potentially modifiable factors and risk of
prostate and ovarian cancer.
In Chapter 1, I describe primary prevention strategies for reducing cancer burden,
clinical and epidemiological features of prostate and ovarian cancers, and methodological
approaches in observational epidemiology. In Chapter 2, I present an overview of the use of
MR in cancer epidemiology, the strengths and limitations of MR when examining cancer as
an outcome, and illustrative examples of studies employing this method to evaluate the role
of modifiable factors in cancer risk. In Chapter 3, there was little evidence of an association
of blood selenium with overall prostate cancer risk but weak evidence for an association with
risk of advanced prostate cancer. In Chapter 4, there was weak evidence supporting an
inverse association of serum calcium with overall prostate cancer risk but little evidence to
support an association with advanced prostate cancer risk. In Chapter 5, 2 of 12 previously
reported ovarian cancer risk factors showed evidence of association with invasive epithelial
ovarian cancer (EOC) risk and 8 showed evidence of association with risk of one or more
invasive EOC histotypes. In Chapter 6, there was strong evidence for an association of
HMG-CoA reductase inhibition with lower EOC risk among women in the general
population and in BRCA1/2 mutation carriers. In Chapter 7, I summarise findings presented
in this thesis, consider their public health and clinical implications, discuss recent Mendelian
randomization studies examining the association of other lifestyle and molecular factors in
risk of prostate and ovarian cancers, and discuss possible future directions for MR analyses
examining modifiable determinants of prostate and ovarian cancer risk.
Date of Award24 Mar 2020
Original languageEnglish
Awarding Institution
  • University of Bristol
SupervisorSarah J Lewis (Supervisor), Caroline L Relton (Supervisor) & Richard M Martin (Supervisor)

Cite this

'